By Professor Adam Jaffe

Conference Abstracts

Stelzer-Braid S; Tovey E; Willenborg C; Toelle B; Ampon R; Garden F; Oliver B; Strachan R; Belessis Y; Jaffe A; Reddel H; Crisafulli D; Marks G; Rawlinson W, 2015, 'Absence of seasonal peaks in human rhinovirus and asthma exacerbations in a cohort of children with asthma contrasts to community incidence of disease exacerbations', in Respirology, Wiley, Vol. 20, pp. 54 - 54, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000351464400143&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Stelzer-Braid S; Toelle B; Willenborg C; Garden F; Strachan R; Jaffe A; Oliver B; Belessis Y; Reddel H; Marks G; Rawlinson W; Tovey E, 2014, 'SNEEZING LEADS TO WHEEZING: RHINOVIRUS INFECTION IN THE STUDY OF ASTHMA, VIRUSES AND ENVIRONMENT (SAVE) COHORT', in RESPIROLOGY, WILEY-BLACKWELL, Vol. 19, pp. 38 - 38, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000333238100092&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Tovey ER; Stelzer-Braid S; Toelle BG; Willenborg CM; Reddel HK; Garden FL; Jaffe A; Strachan R; Oliver BG; Belessis YC; Marks GB; Rawlinson WD, 2014, 'Asthma Symptoms and Rhinovirus In A Longitudinal Children's Cohort', in JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, MOSBY-ELSEVIER, CA, San Diego, Vol. 133, pp. AB285 - AB285, presented at Annual Meeting of the American-Academy-of-Allergy-Asthma-and-Immunology (AAAAI), CA, San Diego, 28 February 2014 - 04 March 2014, http://dx.doi.org/10.1016/j.jaci.2013.12.1010

Media

Waters S; Jaffe A, 2019, Patients’ avatars being used to test cystic fibrosis drugs, , https://newsroom.unsw.edu.au/news/health/patients%E2%80%99-avatars-being-used-test-cystic-fibrosis-drugs

Waters S; Jaffe A, 2019, Mini-organ unlock new understanding about drug and disease, , https://www.abc.net.au/radionational/programs/healthreport/

Waters S; Jaffe A, 2019, AVATARS: A revolution in cystic fibrosis treatment. INSPIRE Research Australia, , https://issuu.com/researchaustralia/docs/inspire_issue_13_final

Waters S; Jaffe A, 2019, Avatars-a-game-changer-for-children-with-cystic-fibrosis, , https://www.schn.health.nsw.gov.au/news/articles/2019/07/avatars-a-game-changer-for-children-with-cystic-fibrosis

Waters S; Jaffe A, 2019, New treatment giving hope to kids with cystic fibrosis, , https://www.youtube.com/watch?time_continue=1&v=66eXL0fy1JA&feature=emb_logo

Waters S; Prentice B; Jaffe A, 2018, Avatars take lead role in future CF therapy., , https://www.ausdoc.com.au/therapy-update/avatars-take-lead-role-future-cf-therapy

Preprints

Homaira N; Chan M; Owens L; Thomsen A; Gray M; Chuang S; Prentice B; Belessis Y; Islam S; Foster J; Jaffe A, 2024, Parent/carers opinions about COVID-19 vaccination for children with chronic lung diseases, , http://dx.doi.org/10.22541/au.170666146.66053164/v1

Dayaratne WL; Torres-Cadena R; Schmitt BP; Westrick EM; Jaffe A, 2023, Hybrid bronzes: mixed-valence organic-inorganic metal oxides as a tunable material platform, , http://dx.doi.org/10.26434/chemrxiv-2023-v6h2h

Hartley NA; Pugh SM; Xu Z; Leong DCY; Jaffe A; Forse AC, 2023, Quinone-functionalised carbons as new materials for electrochemical carbon dioxide capture, , http://dx.doi.org/10.26434/chemrxiv-2023-ls7mc-v2

Stiboy E; Chan M; Islam MS; L GS; Lui K; Jaffe A; Homaira N, 2022, Variation in clinical practice guidelines for use of palivizumab in preventing severe respiratory syncytial viral (RSV) disease in high-risk infants, , http://dx.doi.org/10.22541/au.166419726.62754781/v1

McKnight L; Schultz A; Vidic N; Palmer E; Jaffe A, 2022, Learning to make a difference for chILD: Value creation through network collaboration and team science, , http://dx.doi.org/10.22541/au.166740302.29601419/v1

Stiboy E; Chan M; Islam MS; L GS; Lui K; Jaffe A; Homaira N, 2022, Variation in clinical practice guidelines for use of palivizumab in preventing severe respiratory syncytial viral (RSV) disease in high-risk infants, , http://dx.doi.org/10.22541/au.166419726.62754781/v2

Wong S; Awatade N; Astore M; Allan K; Carnell M; Slapetova I; Chen P-C; Capraro A; Fawcett L; Whan R; Griffith R; Ooi C; Kuyucak S; Jaffe A; Waters S, 2021, In silicoand functional characterisation of an ultra-rareCFTRmutation identifies novel lasso motif interactions regulating channel gating, , http://dx.doi.org/10.1101/2021.12.12.472297

Wong S; Awatade N; Astore M; Allan K; Carnell M; Slapetova I; Chen P-C; Setiadi J; Pandzic E; Fawcett L; Widger J; Whan R; Griffith R; Ooi C; Kuyucak S; Jaffe A; Waters S, 2021, Molecular dynamics and theratyping in airway and gut organoids reveal R352Q-CFTR conductance defect, , http://dx.doi.org/10.1101/2021.08.11.456003

Jaffe A; Ziebel M; Halat DM; Biggins N; Murphy R; Chakarawet K; Reimer JA; Long JR, 2020, Selective, High-Temperature O2 Adsorption in Chemically Reduced, Redox-Active Iron-Pyrazolate Metal–Organic Frameworks, , http://dx.doi.org/10.26434/chemrxiv.9922541

Jaffe A; Ziebel M; Halat DM; Biggins N; Murphy R; Chakarawet K; Reimer JA; Long JR, 2020, Selective, High-Temperature O2 Adsorption in Chemically Reduced, Redox-Active Iron-Pyrazolate Metal–Organic Frameworks, , http://dx.doi.org/10.26434/chemrxiv.9922541.v3

Jaffe A; Ziebel M; Halat D; Biggins N; Murphy R; Chakarawet K; Reimer J; Long J, 2020, Selective, High-Temperature O2 Adsorption in Chemically Reduced, Redox-Active Iron-Pyrazolate Metal–Organic Frameworks, , http://dx.doi.org/10.26434/chemrxiv.9922541.v4

Jaffe A; Ziebel M; Halat DM; Biggins N; Murphy R; Chakarawet K; Reimer JA; Long JR, 2019, Selective, High-Temperature O2 Adsorption in Chemically Reduced, Redox-Active Iron-Pyrazolate Metal–Organic Frameworks, , http://dx.doi.org/10.26434/chemrxiv.9922541.v2

Jaffe A; Ziebel M; Halat DM; Biggins N; Murphy R; Chakarawet K; Reimer JA; Long JR, 2019, Selective, High-Temperature O2 Adsorption in Chemically Reduced, Redox-Active Iron-Pyrazolate Metal–Organic Frameworks, , http://dx.doi.org/10.26434/chemrxiv.9922541.v1

Stick SM; Foti A; Ware RS; Tiddens HAWM; Clements BS; Armstrong DS; Selvadurai H; Tai A; Cooper PJ; Byrnes CA; Belessis Y; Wainwright C; Jaffe A; Robinson P; Saiman L; Sly PD, The Effect of Azithromycin on Structural Lung Disease in Infants with Cystic Fibrosis (COMBAT CF): A Phase 3, Randomised, Double-Blind, Placebo-Controlled Clinical Trial, , http://dx.doi.org/10.2139/ssrn.3990938

Other

Strachan RE; Jaffé A, 2011, Recommendations for managing paediatric empyema thoracis,

Back to profile page